{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:08:18Z","timestamp":1769004498666,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T00:00:00Z","timestamp":1459123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12264-016-0022-0","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T01:20:11Z","timestamp":1459128011000},"page":"383-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Smoking and Serum Lipid Profiles in Schizophrenia"],"prefix":"10.1007","volume":"32","author":[{"given":"Hui-Mei","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Long","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-De","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jair C.","family":"Soars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","volume":"76","author":"J Leon de","year":"2005","unstructured":"de Leon J, Diaz F. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005, 76: 135\u2013157.","journal-title":"Schizophr Res"},{"key":"22_CR2","first-page":"371","volume":"21","author":"M Sagud","year":"2009","unstructured":"Sagud M, Mihaljevi\u0107-Peles A, M\u00fcck-Seler D, Pivac N, Vuksan-Cusa B, Brataljenovi\u0107 T, et al. Smoking and schizophrenia. Psychiatr Danub 2009, 21: 371\u2013375.","journal-title":"Psychiatr Danub"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ps.201200143","volume":"64","author":"F Dickerson","year":"2013","unstructured":"Dickerson F, Stallings CR,\u00a0Origoni AE, Vaughan C, Khushalani S, Schroeder J, et al. Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999\u20132011. Psychiatr Serv 2013, 64: 44\u201350.","journal-title":"Psychiatr Serv"},{"issue":"2","key":"22_CR4","doi-asserted-by":"crossref","first-page":"e30937","DOI":"10.1371\/journal.pone.0030937","volume":"7","author":"XY Zhang","year":"2012","unstructured":"Zhang XY, Liang J, Chen da C, Xiu MH, He J, Cheng W, et al. Cigarette\u00a0smoking\u00a0in male patients with chronic schizophrenia in a Chinese population: prevalence and relationship to clinical phenotypes. PLoS One 2012, 7(2): e30937.","journal-title":"PLoS One"},{"issue":"2\u20133","key":"22_CR5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2005.04.016","volume":"79","author":"JM Williams","year":"2005","unstructured":"Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res 2005, 79(2\u20133): 323\u2013335.","journal-title":"Schizophr Res"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","volume":"29","author":"V Kumari","year":"2005","unstructured":"Kumari V, & Postma P. Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 2005, 29: 1021\u20131034.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"22_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/YCO.0b013e3283366643","volume":"23","author":"G Winterer","year":"2010","unstructured":"Winterer G. Why do patients with\u00a0schizophrenia\u00a0smoke? Curr Opin Psychiatry 2010, 23(2):112\u2013119.","journal-title":"Curr Opin Psychiatry"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/bs.irn.2015.07.002","volume":"124","author":"RE Featherstone","year":"2015","unstructured":"Featherstone RE,\u00a0Siegel SJ. The Role of Nicotine in\u00a0Schizophrenia. Int Rev Neurobiol\u00a02015, 124: 23\u201378.","journal-title":"Int Rev Neurobiol"},{"key":"22_CR9","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.2337\/diacare.27.8.2088-a","volume":"27","author":"G Boehm","year":"2004","unstructured":"Boehm G, Racoosin JA, Laughren TP, Katz R. Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement. Diabetes Care 2004, 27: 2088\u20132089.","journal-title":"Diabetes Care"},{"issue":"Suppl 7","key":"22_CR10","first-page":"4","volume":"65","author":"DE Casey","year":"2004","unstructured":"Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, et al. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry 2004, 65(Suppl 7): 4\u201318.","journal-title":"J Clin Psychiatry"},{"key":"22_CR11","first-page":"21","volume":"23","author":"J Yogaratnam","year":"2013","unstructured":"Yogaratnam J, Biswas N, Vadivel R, Jacob R. Metabolic complications of schizophrenia and antipsychotic medications\u2013an updated review. East Asian Arch Psychiatry 2013, 23: 21\u201328.","journal-title":"East Asian Arch Psychiatry"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ajp.2013.12.019","volume":"9","author":"H Mabrouk","year":"2014","unstructured":"Mabrouk H, Mechria H, Mechri A, Azizi I, Neffati F, Douki W, et al. Paraoxonase 1 activity and lipid profile in schizophrenic patients. Asian J Psychiatr 2014, 9: 36\u201340.","journal-title":"Asian J Psychiatr"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.schres.2013.07.051","volume":"150","author":"X Wu","year":"2013","unstructured":"Wu X, Huang Z, Wu R, Zhong Z, Wei Q, Wang H, et al. The comparison of glycometabolism parameters and lipid profiles between drug-naive, first-episode schizophrenia patients and healthy controls. Schizophr Res 2013, 150: 157\u2013162.","journal-title":"Schizophr Res"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-7435(03)00110-5","volume":"37","author":"K Maeda","year":"2003","unstructured":"Maeda K, Noguchi Y, & Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med 2003, 37: 283\u2013290.","journal-title":"Prev Med"},{"issue":"12","key":"22_CR15","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1253\/circj.CJ-14-0638","volume":"78","author":"K Takata","year":"2014","unstructured":"Takata K, Imaizumi S, Kawachi E, Suematsu Y, Shimizu T, Abe S, et al. Impact of cigarette\u00a0smoking\u00a0cessation on high-density lipoprotein functionality. Circ J 2014, 78(12): 2955\u20132962.","journal-title":"Circ J"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1741-7015-11-60","volume":"11","author":"T Xu","year":"2013","unstructured":"Xu T, Holzapfel C, Dong X, Bader E, Yu Z, Prehn C, et al. Effects of\u00a0smoking\u00a0and\u00a0smoking\u00a0cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med 2013, 11:60.","journal-title":"BMC Med"},{"issue":"2","key":"22_CR17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4306\/pi.2011.8.2.149","volume":"8","author":"SS Lee","year":"2011","unstructured":"Lee SS, Seo JS, Kim SR, Jeong JE, Nam BW, Lee JY, et al. The changes of blood glucose control and\u00a0lipid\u00a0profiles\u00a0after short-term\u00a0smoking\u00a0cessation in healthy males. Psychiatry Investig 2011, 8(2):149\u2013154.","journal-title":"Psychiatry Investig"},{"key":"22_CR18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2011.01.003","volume":"215","author":"J Lee","year":"2011","unstructured":"Lee J and Cooke JP. The role of nicotine in the pathogenesis of atherosclerosis. Atherosclerosis 2011, 215: 281\u2013283.","journal-title":"Atherosclerosis"},{"issue":"14","key":"22_CR19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jpsychires.2010.02.015","volume":"44","author":"XY Zhang","year":"2010","unstructured":"Zhang XY, Zhang RL, Pan M, Chen da C, Xiu MH, Kosten TR. Sex\u00a0difference in the prevalence of\u00a0smoking\u00a0in Chinese schizophrenia. J Psychiatr Res 2010, 44(14): 986\u2013988.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"22_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald, W.T., R.I. Levy, and D.S. Fredrickson. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 1972, 18(6): 499\u2013502.","journal-title":"Clinical chemistry"},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1192\/bjp.186.3.215","volume":"186","author":"MC Aguilar","year":"2005","unstructured":"Aguilar MC, Gurpegui M, Diaz FJ, de Leon J. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br J Psychiatry 2005, 186: 215\u2013221.","journal-title":"Br J Psychiatry"},{"key":"22_CR22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(02)00324-X","volume":"27","author":"RC Smith","year":"2002","unstructured":"Smith RC, Singh A, Infante M, Khandat A, Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 2002, 27: 479\u2013497.","journal-title":"Neuropsychopharmacology"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/00048670903493348","volume":"44","author":"CY Wang","year":"2010","unstructured":"Wang CY, Xiang YT, Weng YZ, Bo QJ, Chiu HF, et al. Cigarette smoking in patients with schizophrenia in China: prospective, multicentre study. Aust N Z J Psychiatry 2010, 44: 456\u2013462.","journal-title":"Aust N Z J Psychiatry"},{"key":"22_CR24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00001756-199512290-00079","volume":"7","author":"K Rasmussen","year":"1995","unstructured":"Rasmussen K, & Czachura JF. Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons. Neuroreport 1995, 7: 329\u2013332.","journal-title":"Neuroreport"},{"issue":"1","key":"22_CR25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","volume":"114","author":"J Lally","year":"2015","unstructured":"Lally J, MacCabe JH. Antipsychotic medication in\u00a0schizophrenia: a\u00a0review. Br Med Bull. 2015, 114(1): 169\u2013179.","journal-title":"Br Med Bull."},{"issue":"20","key":"22_CR26","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM198811173192005","volume":"319","author":"NL Benowitz","year":"1988","unstructured":"Benowitz, N.L.. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med, 1988, 319(20): 1318\u20131330.","journal-title":"N Engl J Med"},{"key":"22_CR27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.pnpbp.2010.03.010","volume":"34","author":"VE Barakauskas","year":"2010","unstructured":"Barakauskas VE, Ypsilanti AR, Barr AM, Innis SM, Honer WG, Beasley CL. Effects of sub-chronic clozapine and haloperidol administration on brain lipid levels. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34: 669\u2013673.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"22_CR28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.genhosppsych.2012.04.002","volume":"34","author":"J Watanabe","year":"2012","unstructured":"Watanabe J, Suzuki Y, Sugai T, Fukui N, Ono S, Tsuneyama N, et al. The lipid profiles in Japanese patients with schizophrenia treated with antipsychotic agents. Gen Hosp Psychiatry 2012, 34: 525\u2013528.","journal-title":"Gen Hosp Psychiatry"},{"key":"22_CR29","doi-asserted-by":"publisher","unstructured":"Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, et al. Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst 2014; 106: (11). pii: dju294. doi: 10.1093\/jnci\/dju294 .","DOI":"10.1093\/jnci\/dju294"},{"key":"22_CR30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0306-4530(97)00076-0","volume":"23","author":"ML Sopori","year":"1998","unstructured":"Sopori ML, Kozak W, Savage SM, Geng Y, Soszynski D, Kluger MJ, et al. Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 1998, 23: 189\u2013204.","journal-title":"Psychoneuroendocrinology"},{"key":"22_CR31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nri803","volume":"2","author":"M Sopori","year":"2002","unstructured":"Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002, 2: 372\u2013377.","journal-title":"Nat Rev Immunol"},{"key":"22_CR32","doi-asserted-by":"crossref","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010, 34: J258\u2013265.","journal-title":"J Autoimmun"},{"key":"22_CR33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00213-008-1295-4","volume":"201","author":"XY Zhang","year":"2008","unstructured":"Zhang XY, Cao LY, Song C, Wu GY, Chen da C, Qi LY, et al. Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics. Psychopharmacology 2008, 201: 383\u2013389.","journal-title":"Psychopharmacology"},{"key":"22_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pnpbp.2012.08.015","volume":"42","author":"AC Altamura","year":"2013","unstructured":"Altamura AC, Pozzoli S, Fiorentini A, Dell\u2019osso B. Neurodevelopment and in- flammatory patterns in schizophrenia in relation to pathophysiology. Prog. NeuroPsychopharmacol. Biol. Psychiatry 2013, 42: 63\u201370.","journal-title":"Prog. NeuroPsychopharmacol. Biol. Psychiatry"},{"issue":"2\u20133","key":"22_CR35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000356538","volume":"21","author":"N M\u00fcller","year":"2014","unstructured":"M\u00fcller N. Immunology of schizophrenia. Neuroimmunomodulation 2014, 21(2\u20133): 109\u2013116.","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"22_CR36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2015, 2 (3): 258\u2013270.","journal-title":"Lancet Psychiatry"},{"key":"22_CR37","doi-asserted-by":"publisher","unstructured":"Watkins CC, Andrews SR. Clinical studies of neuroinflammatory mechanisms in schizophrenia. Schizophr. Res 2015, pii: S0920-9964(15)00362-X. doi: 10.1016\/j.schres.2015.07.018 .","DOI":"10.1016\/j.schres.2015.07.018"},{"issue":"8","key":"22_CR38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","volume":"63","author":"S Potvin","year":"2008","unstructured":"Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 2008, 63 (8): 801\u2013808.","journal-title":"Biol. Psychiatry"},{"key":"22_CR39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011, 70: 663\u2013671.","journal-title":"Biol Psychiatry"},{"key":"22_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0920-9964(98)00034-6","volume":"32","author":"A Lin","year":"1998","unstructured":"Lin A, Kenis G, Bignotti S, Tura GJ, De Jong R, Bosmans E, et al. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res 1998, 32: 9\u201315.","journal-title":"Schizophr Res"},{"key":"22_CR41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0920-9964(00)00094-3","volume":"54","author":"M Maes","year":"2002","unstructured":"Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura GJ, et al. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 2002, 54: 281\u2013291.","journal-title":"Schizophr Res"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-016-0022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-016-0022-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-016-0022-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T21:01:56Z","timestamp":1600376516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-016-0022-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s12264-016-0022-0","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]}}}